Global Apheresis Equipment Market, By Equipment Type (Disposable Apheresis Kits and Apheresis Machines), Technology Type (Centrifugation and Membrane Filtration), Procedure Type (Photopheresis, Plasmapheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Others (Lymphopheresis, lipidpheresis), Application (Renal disorders, Neurological disorders, Hematological disorders, and Other disorders), End Use ( Hospitals and Clinics, Ambulatory Surgical Centers, Blood Donation Centers, and Others) – Industry Trends and Forecast to 2031.
Apheresis Equipment Market Analysis and Size
The global apheresis equipment market is expected to witness steady growth in the coming years. Rising prevalence of blood disorders and increasing need for blood components are the key factors driving the demand for apheresis equipment. Growing number of trauma cases and road accidents necessitating blood transfusions will further augment the market growth. Additionally, rising cases of chronic diseases such as cancer where apheresis plays a vital role in treatment are fueling the sales of advanced apheresis solutions
Data Bridge Market Research analyses that the global apheresis equipment market which was USD 3.7 billion in 2023, expected to reach up to USD 8.65 billion by 2031, and is expected to undergo a CAGR of 11.2% during the forecast period 2024 to 2031. “Disposable apheresis kits” dominates the equipment type segment of the market owing to the growing demand for better methods for diagnosis in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Equipment Type (Disposable Apheresis Kits and Apheresis Machines), Technology Type (Centrifugation and Membrane Filtration), Procedure Type (Photopheresis, Plasmapheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Others (Lymphopheresis, lipidpheresis), Application (Renal disorders, Neurological disorders, Hematological disorders, and Other disorders), End Use ( Hospitals and Clinics, Ambulatory Surgical Centers, Blood Donation Centers, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Asahi Kasei Medical Co., Ltd. (Japan),Terumo Corporation, Inc. (Japan), Eenwal, Inc. (U.S.), Haemonetics Corp. (U.S.),Therakos, Inc. (U.S.),Braun Melsungen AG (Germany),HemaCare Corporation (U.S.),Haemonetics Corporation (U.S.),Miltenyi Biotec (Germany), NxStage Medical (U.S.), Kaneka Medix Corporation (Japan)
|
|
Market Opportunities
|
|
Market Definition
Apheresis equipment refers to medical devices designed for the automated separation of blood components during apheresis procedures. Apheresis is a therapeutic process that involves removing specific components from a patient's blood, such as plasma, platelets, or white blood cells, while returning the remaining blood components back to the patient's circulation. Apheresis equipment typically consists of a machine equipped with centrifugation or filtration systems that enable the separation of blood components based on their physical properties, such as density or size.
Apheresis Equipment Market Dynamics
Drivers
- Technological Advancements
Technological innovations in apheresis equipment have significantly enhanced the efficiency, safety, and usability of these devices. Advanced automation features, improved software algorithms, and the development of disposable kits have streamlined procedures, reduced procedure times, and minimized the risk of adverse events. For instance, the introduction of continuous flow centrifugation and software-guided procedures has led to more precise and effective blood component separation. Additionally, the integration of advanced monitoring systems and connectivity features allows for real-time data analysis and remote monitoring, improving patient outcomes and operational efficiency. As healthcare providers increasingly prioritize the adoption of state-of-the-art technologies to optimize patient care, the demand for advanced apheresis equipment is expected to continue rising globally.
- Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases is driving the demand for apheresis procedures worldwide. Apheresis therapy plays a crucial role in the management of these conditions by removing harmful substances from the blood, such as excess antibodies, toxins, or cancerous cells. With the growing burden of chronic diseases globally, particularly in aging populations and emerging economies undergoing epidemiological transitions, there is a growing demand for effective therapeutic interventions such as apheresis. Moreover, advancements in precision medicine and personalized therapies have expanded the application of apheresis procedures, creating new opportunities for market growth. As healthcare systems strive to address the rising demand for advanced treatment modalities, the market for apheresis equipment is expected to witness sustained growth in the coming
Opportunities
- Expansion in Emerging Markets
As healthcare infrastructure continues to improve and economies develop in regions such as Asia-Pacific, Latin America, and the Middle East, there is a growing demand for advanced medical technologies, including apheresis equipment. Factors such as increasing prevalence of chronic diseases, rising healthcare expenditure, and expanding access to healthcare services are driving the demand for apheresis procedures in these markets. Companies that strategically expand their presence in emerging markets through partnerships, distribution agreements, or direct investments can tap into this growing demand and capitalize on the untapped market potential to addressing the specific needs and preferences of these markets, manufacturers can establish strong footholds, drive revenue growth, and contribute to improving healthcare outcomes on a global scale.
Restraints/Challenges
- High Initial Investment Costs
Apheresis equipment typically requires a significant upfront investment for procurement, installation, and training. The complex technology and specialized components contribute to high costs, which may deter healthcare facilities from adopting or upgrading their apheresis systems. Additionally, maintenance and servicing expenses can further strain budgets over time. This financial barrier could limit market growth, particularly in regions with limited healthcare budgets or reimbursement constraints. Consequently, healthcare providers may opt for alternative treatment modalities or delay equipment upgrades, impacting market expansion.
- Stringent Regulatory Compliance Requirements
The global apheresis equipment market is subject to stringent regulatory standards and certification processes imposed by regulatory authorities such as the FDA (Food and Drug Administration) in the United States and the European Medicines Agency (EMA) in Europe. Compliance with these regulations necessitates rigorous testing, documentation, and quality control measures throughout the manufacturing and distribution processes. Failure to meet regulatory requirements can result in product recalls, fines, or delays in market entry, thereby impeding manufacturers' ability to introduce new or upgraded equipment. Moreover, navigating the regulatory landscape incurs additional time and resources, potentially slowing down innovation and product development cycles. As a result, companies operating in the apheresis equipment market must allocate substantial resources to ensure compliance, which may hinder market growth and innovation.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In May 2023, Terumo Corporation a medical device company launched the first training program of its kind to help cell and gene therapy manufacturers improve their cell collection processes and accelerate the commercialization of therapeutics. It will help to trains the participants in apheresis market for the better skills
- In January 2020, Fresenius Kabi AG a pharmaceutical company inaugurated the USD 32.2 Mn expansion of transfusion and apheresis disposables plant in Dominican Republic. This plant expansion will strengthen the company’s role as a major global exporter of apheresis and plasma collection sets
Apheresis Equipment Market Scope
The market is segmented on the basis of equipment type, technology type, procedure type, application, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Equipment Type
- Disposable Apheresis Kits
- Apheresis Machines
Technology Type
- Centrifugation
- Membrane Filtration
Procedure Type
- Photopheresis
- Plasmapheresis
- LDL Apheresis
- Plateletpheresis
- Leukapheresis
- Erythrocytapheresis,
- Others
- Lymphopheresis
- lipidpheresis
Application
- Renal Disorders
- , Neurological Disorders
- Hematological Disorders
- Other Disorders
End User
- Hospitals and Clinic
- Ambulatory Surgical Centers
- Blood Donation Centers
- Others
Apheresis Equipment Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided country, Equipment Type, Technology Type, Procedure Type, Application, End User as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
North America is expected to be the largest market for apheresis equipment market due to a strong presence of leading players in the region. The U.S. is home to many large multinational companies, such as Haemonetics Corporation and Terumo BCT, which have a significant market share in blood component collection and therapeutic apheresis products globally.
Asia Pacific is expected to be the fastest-growing market for apheresis equipment, which is expected to grow at a CAGR of over 10.2% during the forecast period. The growth of the market in Asia Pacific is attributed to the large patient pool, increasing healthcare expenditure, and improving healthcare infrastructure in the region
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The market also provides you with a detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2016-2021.
Competitive Landscape and Apheresis Equipment Market Share Analysis
The market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Asahi Kasei Medical Co., Ltd. (Japan)
- Terumo Corporation, Inc. (Japan)
- Eenwal, Inc. (U.S.)
- Haemonetics Corp. (U.S.)
- Therakos, Inc. (U.S.)
- Braun Melsungen AG (Germany)
- HemaCare Corporation (U.S.)
- Haemonetics Corporation (U.S.)
- Miltenyi Biotec (Germany)
- NxStage Medical (U.S.)
- Kaneka Medix Corporation (Japan)
SKU-